EP4214240
AND-CCR8 MÓTEFNI
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
27.7.2022EP published:
9.10.2024EP application number:
22754752.8
EP translation filed:
22.11.2024Grant published:
15.12.2024EPO information:
European Patent Register
Max expiry date:
26.7.2042Expiry date:
26.7.2026Next due date:
31.7.2026
Title in English:
ANTI-CCR8 ANTIBODIESLanguage of the patent:
English
Timeline
Today
27.7.2022EP application
9.10.2024EP Publication
22.11.2024Translation submitted
15.12.2024Registration published
26.7.2026Expires
Owner
Name:
AbbVie Inc.Address:
1 N. Waukegan Road, North Chicago, IL 60064, US
Inventor
Name:
MCCLUSKEY, Andrew, J.Address:
Chicago, IL 60064, US
Name:
SCHMIDT PAUSTIAN, Amanda, M.Address:
Chicago, IL 60064, US
Name:
SEAGAL, JaneAddress:
Chicago, IL 60064, US
Name:
WILSBACHER, Julie, L.Address:
Chicago, IL 60064, US
Agent
Name:
Novagraaf BrevetsAddress:
Bâtiment O2, 2 rue Sarah Bernhardt CS90017, FR
Priority
Number:
202163226118 PDate:
27.7.2021Country:
US
Classification
Categories:
C07K 16/28, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 4
Paid: 7.7.2025
Expires: 26.7.2026
Payer: Árnason Faktor ehf.